MABAX
Price
$18.51
Change
-$0.45 (-2.37%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

MABAX vs RMFCX

Header iconMABAX vs RMFCX Comparison
Open Charts MABAX vs RMFCXBanner chart's image
BlackRock Large Cap Focus Value Instl
Price$18.51
Change-$0.45 (-2.37%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
MABAX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MABAX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MABAX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. MABAX (1.8B). MABAX pays higher dividends than RMFCX: MABAX (1.99) vs RMFCX (1.69). MABAX was incepted earlier than RMFCX: MABAX (48 years) vs RMFCX (23 years). MABAX is a more actively managed with annual turnover of: 80.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than MABAX: RMFCX (250) vs MABAX (2000000). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. MABAX (6.76). RMFCX return over 5 years is better than : 40.39 vs. MABAX (0.42).
MABAXRMFCXMABAX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence48 years23 years-
Gain YTD4.85711.42343%
Front LoadN/AN/A-
Min. Initial Investment2000000250800,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.8B98.7B2%
Annual Yield % from dividends1.991.69118%
Returns for 1 year6.7612.6354%
Returns for 3 years7.0614.1650%
Returns for 5 years0.4240.391%
Returns for 10 years-16.3861.84-26%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc